Navigation Links
Ira Haimowitz, PhD, EVP, Group Director, Intelligence and Analytics at The CementBloc, to Present at Aberdeen Group Inaugural Business Analytics Summit
Date:11/10/2011

NEW YORK, Nov. 10, 2011 /PRNewswire/ -- Dr. Ira J. Haimowitz, Executive Vice President, Group Director, Intelligence and Analytics at The CementBloc, will be featured on an expert panel at the inaugural Business Analytics Summit, sponsored by the Aberdeen Group, at the Seaport Hotel in Boston on November 16, 2011.

The summit, titled "Driving New Insight for Line-of-Business Decisions," features the latest business thinkers, corporate leaders, and cutting-edge practices designed to provide insights into the improved visibility of business intelligence and analytics. Dr. Haimowitz will be participating in a panel entitled "Creating an Effective Partnership Between IT and Business." He will bring to the panel his unique perspective on the use of technology in pharmaceutical sales and marketing.

For over 20 years, Dr. Haimowitz has provided healthcare clients with innovative solutions for relationship marketing, segmentation, operations, measurement, and optimization. He has also enabled clients to evaluate the return on investment of their multichannel consumer and professional advertising campaigns.

Prior to joining The CementBloc, Dr. Haimowitz was Vice President, Group Director of Insights and Optimization at Wunderman, leading a team deploying analytics across healthcare, financial services, and consumer packaged goods. He has also spent 9 years on the manufacturer side as a director and team leader for pharmaceutical companies Pfizer and Organon.

Dr. Haimowitz received his PhD in computer science from Massachusetts Institute of Technology in 1994, and his MPhil from Cambridge University in computer speech and language processing. He has spoken and published extensively, and has also served for 7 years on the board of the Pharmaceutical Management Science Association, including a term as President in 2006. Dr. Haimowitz recently authored the book Healthcare Relationship Marketing, from Gower Press, and has a blog by the same name (http://healthcarerm.blogspot.com/).

For reservations to attend this presentation, call the Aberdeen Group at 617-854-5200.

About The CementBloc: The CementBloc is a leading multichannel health and wellness creative agency based in New York. Founded in 2000 by Susan Miller Viray and Rico Viray, The CementBloc is also a founding member of Indigenus, an independent global network of entrepreneurial healthcare creative agencies.

http://www.thecementbloc.com


'/>"/>
SOURCE The CementBloc
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Restrictive Compliance Environment Weakens Professional and Trade Relations Group Impact
2. Global Pharm Holdings Group, Inc. Completes Acquisition of Qingdao Likang Pharmaceutical Co., Ltd.
3. CRC Health Group Announces Acquisition of North Carolinas Mountain Health Solutions
4. Vermillion Engages Liolios Group to Lead Investor Relations Program
5. ArjoHuntleigh Awarded Vascular Compression Contract With HealthTrust Purchasing Group
6. Simcere Pharmaceutical Group to Announce Third Quarter 2011 Financial Results on Monday, November 14, 2011
7. Publicis Healthcare Communications Group Redefines Publicis Groupes Healthcare Client Offering by Joining Forces with Digitas Health and Razorfish Health
8. Herborium Group Shareholders Update
9. MiMedx Group Announces Third Quarter 2011 Results
10. Global Sources opens six trade shows with worlds top buyers registered to attend including Adidas, AEON, American Greetings, Brookstone, Casino, Coles Group, Mothercare, Next, Sears and Woolworths
11. Perrigo Expands Infant Formula Distribution in China With Founder Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... , March 30, 2017  Akcea Therapeutics, a subsidiary ... initiation of a Phase 2b dose-ranging study of AKCEA-APO(a)-L ... disease. The goal of the study is to determine ... Rx in a planned Phase 3 cardiovascular outcome ... of Akcea,s strategic collaboration with Novartis to develop and ...
(Date:3/30/2017)... DUBLIN , Mar 30, 2017 ... "Hemodialysis And Peritoneal Dialysis Market Size & Forecast, By Type ... (Home-based, Hospital-based), And Trend Analysis From 2014 To 2025" ... ... market is expected to reach USD 108.5 billion by 2025. ...
(Date:3/29/2017)... Research and Markets has announced the ... Forecast By Type (Insource IONM, Outsource IONM), By Region And ... offering. ... The global Intraoperative Neuromonitoring (IONM) market is expected to ... is anticipated to witness significant growth in the forecast period, ...
Breaking Medicine Technology:
(Date:3/30/2017)... ... 2017 , ... According to the American Society of Plastic Surgeons (ASPS), over ... top 5 most popular minimally-invasive cosmetic procedures in the country. With summer close, it’s ... the next 8-10 weeks. For anyone considering a hair removal procedure, there are a ...
(Date:3/30/2017)... ... March 30, 2017 , ... AudioEducator, ... conference “ Preventing Hospital Readmissions Through Discharge Planning ” with noted expert Sue ... ET. This conference discusses strategies to prevent readmissions in light of the most ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Professional Squash ... has enlisted New York City-based sports and entertainment marketing firm Leverage Agency as ... opportunities for the Professional Squash Association (PSA), which includes first-time ever title sponsorship, ...
(Date:3/29/2017)... ... 2017 , ... Sublime Naturals and its founder, Kathy Heshelow, are big fans ... been used for thousands of years. , "The West has caught on, and has ... How to Use it For Your Wellness. Overcome Inflammation, Enemy of the Body. " ...
(Date:3/29/2017)... Indianapolis, IN (PRWEB) , ... March 29, 2017 ... ... Benefits Study, this webinar provides insight into the challenges employers face in trying ... the complexity of managing employee benefits programs? Adding to the growing complexity, ...
Breaking Medicine News(10 mins):